B-TEMIA
[PRIVATE]Exoskeletons · HQ: Saint-Augustin-de-Desmaures, Quebec · Est. 2010 · 1 model registered · 1 deployments
As of Sep 2026, DEPLOY verifies B-TEMIA: 1 model, 1 deployment across 1 region. 2 sources back the record.
Ownership
PRIVATE
Capital / Funding
Undisclosed
Headquarters
Saint-Augustin-de-Desmaures, Quebec
IP / Patents
Undisclosed
Platform Models
1
Audited Incidents
0
Overview
Canadian bio-robotics company developing Dermoskeleton™ technology for human mobility augmentation. Its flagship product Keeogo is a powered lower-limb exoskeleton that provides motorized knee assistance for stroke patients and individuals with mobility impairments in rehabilitation settings. B-TEMIA received FDA 510(k) clearance for Keeogo in September 2020 and was acquired by Wistron Medical Tech Holding Company in 2025 through a court-approved stalking horse agreement following insolvency proceedings
Clean safety record across 1 verified deployment. Funding runway warrants monitoring: last known round 139 months ago.
- EXOSKELETON
Key Facts
Safety & Regulatory Posture
No incidents on record for B-TEMIA.
Leadership & Founders
Founding Team
cofounder · no longer at company
Key Former Leadership (2 Tracked)
Partnerships & Commercial Deployments
Key Recurring Partners
Recent Verified Partnerships
- Partnership
MOST RECENT
Operator Customers & Fleet Integrators
Platform Models
Deployments
Sectors & Applications
FAQ
What is B-TEMIA?
Canadian bio-robotics company developing Dermoskeleton™ technology for human mobility augmentation. Its flagship product Keeogo is a powered lower-limb exoskeleton that provides motorized knee assistance for stroke patients and individuals with mobility impairments in rehabilitation settings. B-TEMIA received FDA 510(k) clearance for Keeogo in September 2020 and was acquired by Wistron Medical Tech Holding Company in 2025 through a court-approved stalking horse agreement following insolvency proceedings
What does B-TEMIA make?
B-TEMIA has 1 robot model on the DEPLOY registry: B-TEMIA Keeogo (B-TEMIA builds physical robots).
Is B-TEMIA publicly traded?
B-TEMIA is not independently listed on public markets; it is part of Wistron Medical Tech Holding Company (Taiwan on the DEPLOY registry.
Who competes with B-TEMIA?
On the DEPLOY registry, peer companies to B-TEMIA building in the same form factors include Fourier Intelligence, Honda, Lockheed Martin, Wandercraft.
Who is the CEO of B-TEMIA?
David Quitman is the ceo of B-TEMIA, per the DEPLOY registry.
How can I invest in B-TEMIA?
B-TEMIA has no separately traded stock; it is owned by Wistron Medical Tech Holding Company (Taiwan (the parent is the entity that trades, where it is public).
Where is B-TEMIA headquartered?
B-TEMIA is headquartered in Saint-Augustin-de-Desmaures, Quebec, Canada.
Who owns B-TEMIA?
B-TEMIA is owned by Wistron Medical Tech Holding Company (Taiwan, per the DEPLOY registry.
Where does B-TEMIA operate robots?
B-TEMIA operates 1 verified deployment, including at Montreal.
How many robots has B-TEMIA deployed?
DEPLOY has 1 verified B-TEMIA deployment on record at sites including Montreal. That is a count of distinct field deployments each backed by sourced evidence, not a manufacturer's claimed unit total; it updates as new sites are verified.
Is B-TEMIA a top robotics company?
On DEPLOY's intelligence score, which blends verified deployments, funding, hiring, media, safety, and IP signals, B-TEMIA ranks in roughly the top 69% of companies tracked by the registry.
When was B-TEMIA founded?
B-TEMIA was founded in 2010.
Is B-TEMIA safe?
B-TEMIA has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.